U.S. Stock News

CME Group recently unveiled a wave of product initiatives, including index-based Hockey futures using NHL statistics, Compute futures tied to GPU rental costs with Silicon Data, expanded 24/7 trading for 100-Ounce Silver futures, and new E-nano equity index contracts for finer-grain exposure. Together, these launches highlight CME Group’s push beyond traditional futures into AI infrastructure pricing, sports performance indexes, and retail-friendly metals and equity products, reinforcing its...

Public Service Enterprise Group Incorporated has reported past second-quarter 2026 results, with sales of US$2,554 million and net income of US$334 million, down from US$2,805 million and US$585 million, respectively, a year earlier. While second-quarter profit metrics weakened year on year, the first half of 2026 still showed higher sales of US$6,402 million versus US$6,027 million, highlighting pressure on earnings despite growing revenue. With earnings per share from continuing operations...

Pegasystems’ FedRAMP Expansion And Why It Matters For The Stock Pegasystems (PEGA) has expanded the FedRAMP Class D Certified capabilities of Pega Cloud for Government, a move that ties more of its AI workflow and decisioning tools to sensitive federal workloads. This certification step gives federal agencies more options to use Pegasystems software for mission critical processes under established security standards, which is important context as you assess where the stock fits in a...

With inflation gauges cooling and growth data looking shaky, investors are being pulled between fear of weaker earnings and the hope that the Fed stays on hold. That tug of war has pushed steady dividend payers back into focus for anyone who wants income and fewer surprises. This article looks at 3 US dividend-focused defensive stocks exposed to the latest data, and why each one might deserve a closer look now. The stocks covered below are just a starting sample, and the full screen surfaced...

Inhibrx Biosciences, Inc. reported second-quarter 2026 results, with net loss widening to US$36.65 million and basic loss per share from continuing operations at US$2.34, while first-half losses were broadly similar to the prior year. Alongside these figures, the company highlighted FDA acceptance of its biologics license application for ozekibart in conventional chondrosarcoma, setting a PDUFA goal date of April 14, 2027, and pointed to upcoming Phase 2 data for INBRX-106 in head and neck...

MKS stock has surged over the last few years, yet current checks suggest investors are now paying a premium to its intrinsic value estimate and to standard earnings based multiples. After the recent jump on AI related packaging demand, the key issue is whether that premium leaves enough room for error at today’s valuation. MKS has returned 245.9% over the past 3 years, which puts extra focus on whether the current price still lines up with underlying cash flow potential. AI driven demand in...

International Seaways has delivered a very large 5 year return, yet its valuation picture is more measured, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a sizeable discount while standard multiples look closer to fair. International Seaways has returned about 9x over the past 5 years, which puts extra focus on whether the current price still leaves room for further upside. Future cash flow generation from its fleet and capital allocation decisions can support the...

Simpson Manufacturing stock has delivered a strong 79.4% return over the past 5 years, yet current checks suggest the shares now sit close to their intrinsic value rather than offering a clear bargain. The Discounted Cash Flow (DCF) intrinsic value estimate aligns with this picture of a stock that looks roughly fairly priced at around US$193.78. Over 5 years, Simpson Manufacturing has returned 79.4%, which points to a solid outcome for long-term shareholders, even if the valuation now looks...

In early August 2026, Exelixis reported past second-quarter results showing revenue of US$628.69 million and net income of US$212.05 million, while slightly trimming its full-year 2026 revenue outlook to US$2.50 billion–US$2.55 billion and filing a US$112 million employee stock plan-related shelf registration. Alongside these financial updates, Exelixis highlighted continued progress of its oncology pipeline, including zanzalintinib as a potential second franchise, reinforcing its effort to...

Vaxcyte, Inc. recently reported second-quarter 2026 results showing a wider net loss of US$284.3 million and higher basic loss per share, while also updating investors on the progress of its vaccine pipeline. Alongside the larger first-half loss of US$604.92 million, management highlighted full enrollment of three pivotal VAX-31 adult Phase 3 trials and early-stage progress for VAX-A1 against Group A Streptococcus, underscoring the company’s heavy investment in late- and early-stage vaccine...

Perrigo Company plc recently reported its second-quarter 2026 results, with sales of US$1,022.8 million and net income of US$74.5 million, and reaffirmed full-year 2026 guidance calling for an All In net sales decline of between 5.5% and 1.5%. The quarter marked a shift from a net loss a year earlier to positive earnings per share, even as both quarterly and year-to-date sales fell compared with 2025 and the company remained loss-making over the first half. We’ll now examine how Perrigo’s...

In the past quarter, Reinsurance Group of America, Incorporated reported higher second-quarter 2026 revenue of US$6.64 billion and net income of US$462 million, alongside stronger earnings per share versus a year earlier. The company also raised its regular quarterly dividend to US$0.98 and completed nearly US$100 million of share repurchases under its 2026 buyback program, highlighting an increased focus on shareholder returns. Beyond the headline earnings jump, the combination of higher...

Kennametal Inc. recently reported its fourth-quarter and full-year results for the period ended June 30, 2026, with quarterly sales rising to US$736.61 million and net income reaching US$226.98 million, while full-year sales climbed to US$2.36 billion and net income to US$342.39 million. At the same time, management issued fiscal 2027 sales guidance of US$3.33 billion to US$3.45 billion, underlining confidence in demand across aerospace, defense, energy, and AI data center end-markets and...

Oracle (ORCL) is under pressure as investors weigh credit downgrades, higher bond insurance costs, and a larger debt load in light of heavy AI and cloud infrastructure spending and a delayed gas pipeline linked to its New Mexico AI data center. See our latest analysis for Oracle. Oracle’s share price has been volatile, with a 30-day share price return of 13.61% after a sharper 90-day decline of 21.99%, while the 1-year total shareholder return is down 38.68%. Recent announcements around the...

eBay (EBAY) is back in focus after a strong second quarter earnings beat, rapid growth in live shopping and collectibles, and a key shipping and authentication leadership hire that supports ongoing marketplace expansion. See our latest analysis for eBay. Despite the strong second quarter earnings beat and focus on live shopping, collectibles, and shipping upgrades, recent momentum in eBay’s share price has cooled, with the stock down over the past week and quarter but still showing a positive...

In the past quarter, SolarEdge Technologies reported second-quarter 2026 sales of US$346.25 million and a net loss of US$30.75 million, while also issuing third-quarter revenue guidance of US$310 million to US$340 million and highlighting ongoing rollout of its Nexis home energy system integrated with ConnectDER’s IslandDER adapter. Beyond the improved year-on-year loss reduction, SolarEdge’s Nexis platform and IslandDER integration aim to simplify whole-home backup installations and reduce...

In recent months, multiple law firms, including Robbins Geller and Rosen Law Firm, have filed securities class action lawsuits against Photronics and several senior executives, alleging materially false and misleading statements about revenue outlook, product pipeline, and growth prospects between December 10, 2025 and May 27, 2026. This wave of litigation not only challenges past disclosures but also raises fresh questions about how reliably investors can interpret Photronics’ growth...

In August 2026, Immunome, Inc. reported a higher net loss for the second quarter and first half of the year, with basic loss per share from continuing operations increasing year over year for both periods. On the same day, the company also filed a US$38.54 million shelf registration for 1,500,000 common shares tied to an ESOP-related offering, highlighting an intention to preserve flexibility for future capital raising. With the shares rising over the past week, we'll examine how the...

Bladex Inc. recently completed a US$30,000,000 fixed-income offering of unsecured, unsubordinated Euro medium-term floating rate notes due August 12, 2029, issued at 100% of principal under Regulation S. This new floating rate Eurobond funding adds flexibility to Bladex’s capital structure, potentially supporting future lending capacity and broader balance sheet initiatives. We’ll now examine how this new US$30,000,000 floating rate note issuance could influence Bladex’s existing investment...

In early August 2026, Voya Financial, Inc. reported softer second-quarter earnings, while facing an escalating “no confidence” campaign from major shareholder TOMS Capital that criticized governance, strategy, and execution. At the same time, Voya is pursuing small retirement-focused acquisitions and renewing long-standing client mandates such as Baker Botts’ US$900.00 million 401(k), underscoring the tension between its growth ambitions and shareholder scrutiny over capital deployment and...

Fidelity National Financial recently reported past second-quarter 2026 results, with revenue of US$4,051 million and net income of US$288 million, alongside a quarterly dividend declaration of US$0.52 per share payable on September 30, 2026. The combination of stronger earnings driven by commercial transaction activity, disciplined cost control, and ongoing share repurchases highlights management’s emphasis on both operational efficiency and direct capital returns to shareholders. Next,...

Dole plc’s second-quarter 2026 results showed sales rising to US$2,499.41 million and net income reaching US$25.98 million, alongside a maintained quarterly dividend of US$0.085 per share. Despite higher sales and net income, earnings per share from continuing operations fell year-on-year, highlighting the impact of cost pressures and business mix on profitability. We’ll now examine how stronger sales and net income, paired with steady dividends, affect Dole’s existing investment narrative...

Janus Living (JAN) has completed a $464 million follow on equity offering of 16,000,000 Class A 1 common shares at $29 each, reflecting a discount of $1.0875 per share. See our latest analysis for Janus Living. Janus Living shares have gained momentum in recent months, with a 14.8% 90 day share price return and 29.8% year to date share price return, as investors respond to stronger earnings, raised 2026 guidance and the completed equity raise. If this kind of activity has your attention, it...

In August 2026, USA TODAY Sports launched USA TODAY Sports Fantasy, a US$39.99-per-year fantasy football subscription platform, while Golfweek partnered with REMAX Golf Lifestyles to create a free golf real estate and lifestyle hub for its 2 million monthly users. Together, these moves show USA TODAY expanding beyond traditional news into subscription-based fantasy tools and niche lifestyle experiences that deepen audience engagement. Next, we’ll examine how the new USA TODAY Sports Fantasy...